NDC 68382-252-30 - atorvastatin calcium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68382-252
- Requested NDC
- 68382-252-30
- Package NDCs from labels
- 68382-252-01, 68382-252-05, 68382-252-10, 68382-252-30, 68382-252-77, 68382-252-06, 68382-252-16
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2024-10-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATORVASTATIN - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2024-10-21 | HUMAN PRESCRIPTION DRUG LABEL |
| atorvastatin calcium - A-S Medication Solutions | A-S Medication Solutions | 2021-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68382-252-10 | EA - Each | 68382-252 | e780ebcb-c50e-4ea8-abec-df6448c6cac5 | 1 | 2018-12-13 |
| 68382-252-16 | EA - Each | 68382-252 | 378054c1-81d3-4451-aa08-ac3202eab97f | 1 | 2018-12-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6dc3b477-52b1-4d56-81a0-8d3e311d7b5b | 46eb0d41-4c5a-496c-9084-d0dbd7883b62 | 2021-04-15 | Warnings, Adverse reactions | 6dc3b477-52b1-4d56-81a0-8d3e311d7b5b 46eb0d41-4c5a-496c-9084-d0dbd7883b62 | ||
| Amlodipine besylate and Atorvastatin calcium | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | Dr. Reddy's Laboratories Inc | abee4a34-89cc-d886-192c-32582ab8f024 | 2021-02-16 | Warnings, Adverse reactions | 48A5M73Z4Q |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Dr. Reddy's Laboratories Limited | 6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d | 2020-11-30 | Warnings, Adverse reactions | 259255 48A5M73Z4Q |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Proficient Rx LP | d77e155c-403d-449e-bafd-11c9bd4974dd | 2020-01-01 | Warnings, Adverse reactions | 48A5M73Z4Q |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Vanilla | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | d701c221-9f68-47ff-b766-2f4f1998649f | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Amber | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 7f5e6872-4d26-410e-8afe-16a016f9a399 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Ivory | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 1124ba7d-a328-409b-8c88-e74bb3e501f5 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Honey | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 9c407dc7-fcde-4660-9a06-57bd8a6b867d | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Chestnut | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | f07e8bb2-30ae-4337-ad60-84f55f2ff354 | 2019-10-08 | Warnings | 15FIX9V2JP |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Proficient Rx LP | bd56a76b-5570-46a7-9399-fc110d913bf9 | 2019-10-01 | Warnings, Adverse reactions | 259255 48A5M73Z4Q |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Aphena Pharma Solutions - Tennessee, LLC | c0b4f1a2-0082-4150-8f2b-e7440252b675 | 2019-05-08 | Warnings, Adverse reactions | 48A5M73Z4Q |
| CLE CCC Golden Medium Deep | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | b7a4847f-b84d-4f36-8787-104eccd838a0 | 2018-12-03 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Medium Deep | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | 229c20a3-6288-4ac3-9098-6d1622e906ab | 2018-11-29 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Medium Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | fc90fb8a-44b3-47cd-882e-94ed324ed389 | 2018-11-27 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Medium | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | b585f216-4234-47c5-9a6b-8b133ef48aae | 2018-11-27 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | 14891e26-b3b6-4545-99b1-da914b7f5629 | 2018-11-24 | Warnings | 15FIX9V2JP |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Aphena Pharma Solutions - Tennessee, LLC | ed8e76a5-6b40-47fe-9018-25bfe690a4dd | 2018-10-18 | Warnings, Adverse reactions | 48A5M73Z4Q |
| Additox | TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | BioActive Nutritional, Inc. | 319ee2fe-58e3-495e-bf0d-df201f6fbb1c | 2018-07-18 | Warnings | 15FIX9V2JP |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Cipla USA Inc., | 18fe5990-399d-416c-852f-e14974317b8b | 2018-03-13 | Warnings, Adverse reactions | 259255 48A5M73Z4Q |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Aphena Pharma Solutions - Tennessee, LLC | b16b3805-7e60-447c-b3df-7a9392b63c99 | 2018-02-20 | Warnings, Adverse reactions | 259255 48A5M73Z4Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.